FundedIQ
Biotechnology

Zerigo Health: Funding, Investors & Team (Oct 2026)

Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions. Clarify Medical indicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction.

www.zerigohealth.com LinkedIn La Jolla, United States 11-50 employees
Biopharma Biotechnology Health Care Health Diagnostics Medical Medical Device Therapeutics
Total raised
$43.0M
Rounds
1
Latest
Series B
Oct 2021

Zerigo Health has raised $43.0M across 1 funding round on record, the most recent a Series B of $43.0M announced in Oct 2021.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Zerigo Health Company Profile and Key Stats

Total funding raised
$43.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$43.0M in Oct 2021
Employees
11-50
reported band
Headquarters
La Jolla, United States

Latest funding round on record: Oct 2021.

Zerigo Health Funding Rounds

Date
Round
Amount
Series B
$43.0M

Zerigo Health Founders and Leadership Team

Name
Role
Contact
Martyn Gross
CEO
—

No contact details are on record for this team yet.

Zerigo Health Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
4,401
$31M

Zerigo Health's latest round of $43.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Zerigo Health in Biotechnology and La Jolla

Companies Similar to Zerigo Health

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Zerigo Health Funding FAQs

What does Zerigo Health do?

Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions. Clarify Medical indicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction.

How much funding has Zerigo Health raised?

Zerigo Health has raised $43.0M across 1 round on record. The most recent is a Series B of $43.0M announced in Oct 2021.

When did Zerigo Health last raise funding?

Zerigo Health's most recent funding round on record is a Series B of $43.0M, announced in Oct 2021.

Who is the CEO of Zerigo Health?

Martyn Gross is listed as CEO at Zerigo Health.

Where is Zerigo Health headquartered?

Zerigo Health is based in La Jolla, California, United States.

How many employees does Zerigo Health have?

Zerigo Health is in the 11-50 employee band.

How does Zerigo Health's funding compare to other Biotechnology startups?

Zerigo Health's latest round of $43.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Zerigo Health Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zerigo Health is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.